Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
Hepatitis A and E usually resolve on their own, but hepatitis B and C can cause serious liver disease, including cirrhosis and liver cancer.
A study comparing matched groups of people with and without HIV found that smoking was a powerful cancer risk factor, especially for women.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
The Supreme Court justice, who is undergoing biweekly chemotherapy, says she remains fully able to carry out her work on the court.
A recent Swedish study defined a low-level detectable viral load as between 50 and 999.
Gastrointestinal cancers conference emphasizes patient quality of life.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.